Bumper Offer - Urjas oil Just @ Rs. 1
Betnesol 4 Tablet (20) is a commercial drug that is prescribed in the form of Tablet. It is typically used for the treatment of Allergy, Asthma, Cancer: causes, symptoms, treatment, medicines, prevention and medicines. Betnesol 4 Tablet (20) also has some secondary and off-label uses. These are listed below.
The right dosage of Betnesol 4 Tablet (20) depends on the age, gender, and medical history of the patient. Individual symptoms and route of administration also determines the right dosage. For detailed information on this, read through the dosage section.
The side effects typically associated with Betnesol 4 Tablet (20) include Skin Rash. Apart from the aforementioned side effects, Betnesol 4 Tablet (20) can also lead to other problems, which have been listed below. Such side effects of Betnesol 4 Tablet (20) normally do not last long and go away once the treatment is completed. Please speak with your doctor if these side effects worsen or persist for a longer duration.
In addition, Betnesol 4 Tablet (20)'s effect is Moderate during pregnancy and Safe for lactating mothers. Warnings related to Betnesol 4 Tablet (20)'s effects on the liver, heart and kidney, if any, have been listed below.
Betnesol 4 Tablet (20) is contraindicated in people with pre-existing medical conditions like Liver Disease, Scleroderma, Tuberculosis (TB) as it can result in adverse effects. The section on Betnesol 4 Tablet (20) contraindications lists all such conditions.
Drug interactions for Betnesol 4 Tablet (20) have been reported in the medical literature. A complete list of these interactions is given below.
In addition to the above precautions for Betnesol 4 Tablet (20), it is important to know that it is safe while driving, and is habit-forming.
Betnesol 4 Tablet (20) is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
| 13 - 18 years (Adolescent) |
|
| 2 - 12 years (Child) |
|
Is the use of Betnesol 4 Tablet (20) safe for pregnant women?
Betnesol can have harmful effects in pregnant women. If you experience any discomfort after using Betnesol, then discontinue the use and take your doctor's advice.
Is the use of Betnesol 4 Tablet (20) safe during breastfeeding?
Betnesol is completely safe for breastfeeding women.
What is the effect of Betnesol 4 Tablet (20) on the Kidneys?
Betnesol rarely harms the kidneys.
What is the effect of Betnesol 4 Tablet (20) on the Liver?
Very few cases of side effects of Betnesol on the liver have been reported.
What is the effect of Betnesol 4 Tablet (20) on the Heart?
Very few cases of side effects of Betnesol on the heart have been reported.
Betnesol 4 Tablet (20) should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Betnesol 4 Tablet (20) unless your doctor advises you to do so -
Is this Betnesol 4 Tablet (20) habit forming or addictive?
No, you will not get addicted to Betnesol 4 Tablet (20).
Is it safe to drive or operate heavy machinery when consuming?
Yes, you can operate a vehicle or heavy machinery after taking Betnesol 4 Tablet (20) since it does not cause drowsiness.
Is it safe?
Betnesol 4 Tablet (20) is safe but it is important to consult a doctor before taking it.
Is it able to treat mental disorders?
No, Betnesol 4 Tablet (20) is not used to treat mental disorders.
Interaction between Food and Betnesol 4 Tablet (20)
Due to a lack of research, nothing can be said about the consequences of taking Betnesol 4 Tablet (20) together with food.
Interaction between Alcohol and Betnesol 4 Tablet (20)
Due to lack of research, there is no information about the side effects of taking Betnesol 4 Tablet (20) with alcohol.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 362-370
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 289
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Celestone® (betamethasone)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Cortival (betamethasone valerate)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Diprosone® Ov (betamethasone dipropionate)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 362-370
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 289
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Celestone® (betamethasone)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Cortival (betamethasone valerate)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Diprosone® Ov (betamethasone dipropionate)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 362-370
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 289
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Celestone® (betamethasone)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Cortival (betamethasone valerate)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Diprosone® Ov (betamethasone dipropionate)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 362-370
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 289
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Celestone® (betamethasone)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Cortival (betamethasone valerate)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Diprosone® Ov (betamethasone dipropionate)